Hims & Hers shares jumped nearly 50% in premarket trade on Monday after a report it has ended a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.
FlashNews:
Sharmaine Anna Dobson’s Body of Work Examines Faith, Resilience, Healing and Hope
Author Shirley Pollard Announces “Intriguing Secrets,” a New Book on Unlocking “Magical Mind Power” for Love, Confidence, and Transformation
New Novel Explores Friendship and Second Chances on the French Riviera
Fed will need to be ‘aggressive’ on inflation, says top official
Battered government bonds rebound as oil falls below $100
Germany’s Merz hits out at ‘destructive’ forces as he fights for survival
US news outlets to sue Trump administration over White House ban
Jamie Oliver’s recipes for fish pie pasta bake and tomato and feta lentils
Trump and Xi are the wrong men at the wrong time
ECB launches Pontes to settle tokenized assets without stablecoins
Gary Paul Introduces The Traders Guide: From Main Street to Wall Street, The Whole Story
The Commercial Case for Cooling Bangladesh’s Garment Factories
Botswana Seeks Bigger De Beers Stake
BBC removes 11 Mitchell and Webb comedy sketches from iPlayer
Harry Styles walked eight miles in loafers. Is he ruining his feet? There’s only one way to find out
NEAR jumps nearly 80% in a week as Intents volume nears $30B
US and China Discuss Alerting Each Other to AI National Security Threats
Bambu P2S Combo 3D Printer Review: My Own Little Plastics Factory
How Artificial Intelligence Is Changing the Way People Plan and Book Travel
Home » Hims & Hers stock rockets on reported end to Novo Nordisk weight-loss drug dispute